Alkermes Plc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Alkermes Plc. on March 5, 2024. The filing reports a corporate governance event effective as of March 5, 2024, regarding the expansion of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased its size to eleven (11) directors.
- New Appointment: Nancy S. Lurker was elected to the Board, with an initial term expiring at the 2024 Annual General Meeting.
- Committee Assignments: As of the filing date, Ms. Lurker has not been appointed to any Board committee.
Guidance, Outlook, and Compensation
Compensation Arrangements: Ms. Lurker will receive a new director equity grant and an annual cash retainer. The terms and amounts align with the "Director Compensation" section of the Company's definitive proxy statement filed on May 25, 2023.
Grant Timing: The new director equity grant and a prorated annual equity grant for the 12-month period ending at the 2024 Annual Meeting will be granted in April 2024.
Forfeiture Clause: A prorated portion of the new director equity grant is subject to forfeiture if Ms. Lurker is not re-elected by shareholders at the 2024 Annual Meeting.
Indemnification: The Company and its wholly-owned indirect subsidiary, Alkermes, Inc., will enter into indemnification agreements with Ms. Lurker.
Investor Verification Checklist
- Verify the specific terms of the "Director Compensation" section in the proxy statement filed on May 25, 2023, to determine exact cash and equity amounts.
- Confirm the date of the 2024 Annual General Meeting to understand the term expiration and forfeiture timeline.
- Review the press release dated March 7, 2024 (Exhibit 99.1) for additional context on the appointment.
- Check subsequent filings for Ms. Lurker's committee assignments and the execution of the April 2024 equity grants.